Poonam Pandey passed away after a battle with cervical cancer at 32. (Instagram/PoonamPandey)As model and actress Poonam Pandey passed away after a battle with cervical cancer at 32, it raises concerns about the lack of awareness around cervical cancer, the need for prevention and the stigma around it. And yet there’s a vaccine which, when taken by girls before puberty, can stop its incidence in the first place.
Pandey’s manager said that the actor was diagnosed in the last stage of the dreaded disease sometime ago. Cervical cancer is the second most common cancer among women in India. As per a WHO report released on February 1, new cases of cervical cancer among Indian women is 17.7 per cent.
Abnormal cells start growing and clustering around the cervix, which is the lower, narrow end of the uterus that connects to the vagina. It is caused by the Human Papillomavirus (HPV), which is transmitted during sex. Although the virus is removed by the body’s immune system, if it’s a high risk one, like HPV 16 or HPV 18, the chances of it remaining stubborn and causing cancer jump. There are 200 HPV viruses that sexually active people are infected with at some point in their lives. That doesn’t mean that all will develop cancer but a vaccine is needed to eliminate any risk.
No discernible symptoms in the early stages. In the later stages, patient reports unusual vaginal bleeding, including post-coital bleeding, bleeding between periods or after menopause, watery or foul-smelling vaginal discharge and pelvic pain.
A Pap test can detect cancer cells and should be taken by every girl who is entering adulthood, upwards of 20, along with screening intervals ranging from three to five years.
Cervical cancer is preventable and curable if you get vaccinated against the HPV virus. India now has its own HPV vaccine, Cervavac, which targets four types of HPV infections and should be taken by girls between the ages of nine and 14.
At present, it is commercially available at a cost of Rs 2,000 per dose.
Quadrivalent vaccines prevent the entry of HPV 16, 18, 6 and 11, the four of the most common types of HPV. In this way, they prevent infections, genital warts and eventually cancer. Universal immunisation of girls is recommended.
Over 100 countries with HPV vaccination programmes have seen a decline in cervical cancer cases. By late 2000s, evidence emerged that vaccination reduced the incidence of pre-cancerous lesions. In 2020 and 2021, studies from Sweden and England also demonstrated that vaccination in teenage years could reduce the risk of cervical cancer by over 85 per cent at age 30.